Description:
Pirtobrutinib is a Bruton's tyrosine kinase (BTK) inhibitor and antineoplastic agent.
- Molecular Weight:479.4
- Boiling Point:619.2±55.0 °C(Predicted)
- Purity:>98%
Molecular Formula:
C22H21F4N5O3
Canonical SMILES:
CC(C(F)(F)F)N1C(=C(C(=N1)C2=CC=C(C=C2)CNC(=O)C3=C(C=CC(=C3)F)OC)C(=O)N)N
InChI:
InChI=1S/C22H21F4N5O3/c1-11(22(24,25)26)31-19(27)17(20(28)32)18(30-31)13-5-3-12(4-6-13)10-29-21(33)15-9-14(23)7-8-16(15)34-2/h3-9,11H,10,27H2,1-2H3,(H2,28,32)(H,29,33)/t11-/m0/s1
InChIKey:
FWZAWAUZXYCBKZ-NSHDSACASA-N
Solubility:
Soluble in DMSO
Appearance:
Solid Powder
Storage: Store at -20°C
Synonyms:
BTK inhibitor 16; LY 3527727; LOXO-305; (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1H-pyrazole-4-carboxamide Más detalles se encuentran
aquí